These results indicate that renal homotransplantation can be an effective way of treating patients with terminal uremia. Even during the developmental period of this study the majority of recipient patients achieved a high degree of social and vocational rehabilitation–and if related donors were used the salvage rate 21 months or longer after operation is still 65%. Nevertheless, the procedure is still experimental. The projected fate of patients in whom there is still evidence of low-grade host versus graft activity is unknown. The role of thymectomy or splenectomy in promoting acceptance of the homografts is not proven. Further work is required on the histocompatibility matching techniques. For the momeni. it would seem wisest to regard renal homotransplantation as an effective but incompletely characterized form of palliative therapy.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.